Kao J - Search Results

1

Kao J, Rosenstein BS, Peters S, Milano MT, Kron SJ. Kao J, et al. Ann N Y Acad Sci. 2005 Dec;1066:243-58. doi: 10.1196/annals.1363.012. Ann N Y Acad Sci. 2005. PMID: 16533929 Review.

2

Reirradiation of recurrent and second primary head and neck malignancies: a comprehensive review.

Kao J, Garofalo MC, Milano MT, Chmura SJ, Citron JR, Haraf DJ. Kao J, et al. Cancer Treat Rev. 2003 Feb;29(1):21-30. doi: 10.1016/s0305-7372(02)00096-8. Cancer Treat Rev. 2003. PMID: 12633577 Review.

3

Twice-daily reirradiation for recurrent and second primary head-and-neck cancer with gemcitabine, paclitaxel, and 5-fluorouracil chemotherapy.

Milano MT, Vokes EE, Salama JK, Stenson KM, Kao J, Witt ME, Mittal BB, Argiris A, Weichselbaum RR, Haraf DJ. Milano MT, et al. Among authors: kao j. Int J Radiat Oncol Biol Phys. 2005 Mar 15;61(4):1096-106. doi: 10.1016/j.ijrobp.2004.08.029. Int J Radiat Oncol Biol Phys. 2005. PMID: 15752889 Clinical Trial.

4

Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinoma.

Salama JK, Vokes EE, Chmura SJ, Milano MT, Kao J, Stenson KM, Witt ME, Haraf DJ. Salama JK, et al. Among authors: kao j. Int J Radiat Oncol Biol Phys. 2006 Feb 1;64(2):382-91. doi: 10.1016/j.ijrobp.2005.07.005. Epub 2005 Oct 5. Int J Radiat Oncol Biol Phys. 2006. PMID: 16213104

5

Intensity-modulated radiation therapy in advanced head and neck patients treated with intensive chemoradiotherapy: preliminary experience and future directions.

Milano MT, Vokes EE, Kao J, Jackson W, List MA, Stenson KM, Witt ME, Dekker A, MacCracken E, Garofalo MC, Chmura SJ, Weichselbaum RR, Haraf DJ. Milano MT, et al. Among authors: kao j. Int J Oncol. 2006 May;28(5):1141-51. Int J Oncol. 2006. PMID: 16596230 Clinical Trial.

6

gamma-H2AX as a therapeutic target for improving the efficacy of radiation therapy.

Kao J, Milano MT, Javaheri A, Garofalo MC, Chmura SJ, Weichselbaum RR, Kron SJ. Kao J, et al. Curr Cancer Drug Targets. 2006 May;6(3):197-205. doi: 10.2174/156800906776842957. Curr Cancer Drug Targets. 2006. PMID: 16712457 Review.

7

Development of an automated gamma-H2AX immunocytochemistry assay.

Hou YN, Lavaf A, Huang D, Peters S, Huq R, Friedrich V, Rosenstein BS, Kao J. Hou YN, et al. Among authors: kao j. Radiat Res. 2009 Mar;171(3):360-7. doi: 10.1667/RR1349.1. Radiat Res. 2009. PMID: 19267563

8

Radiobiological rationale and clinical implications of hypofractionated radiation therapy.

Ko EC, Forsythe K, Buckstein M, Kao J, Rosenstein BS. Ko EC, et al. Among authors: kao j. Cancer Radiother. 2011 Jun;15(3):221-9. doi: 10.1016/j.canrad.2010.12.007. Epub 2011 Apr 21. Cancer Radiother. 2011. PMID: 21514198 Review.

9

γ-H2AX kinetics as a novel approach to high content screening for small molecule radiosensitizers.

Fu S, Yang Y, Das TK, Yen Y, Zhou BS, Zhou MM, Ohlmeyer M, Ko EC, Cagan R, Rosenstein BS, Chen SH, Kao J. Fu S, et al. Among authors: kao j. PLoS One. 2012;7(6):e38465. doi: 10.1371/journal.pone.0038465. Epub 2012 Jun 29. PLoS One. 2012. PMID: 22768044 Free PMC article.

10

Combined Inhibition of Epidermal Growth Factor Receptor and Cyclooxygenase-2 as a Novel Approach to Enhance Radiotherapy.

Fu S, Rivera M, Ko EC, Sikora AG, Chen CT, Vu HL, Cannan D, Eisenstein S, Rosenstein BS, Aguirre-Ghiso J, Chen SH, Kao J. Fu S, et al. Among authors: kao j. J Cell Sci Ther. 2011 Oct 13;1(2):S1-002. doi: 10.4172/2157-7013.s1-002. J Cell Sci Ther. 2011. PMID: 23483082 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,825 results

Search Page

Filters